Jungmin Lee

MedicineHealth ProfessionsComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer”.

A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.019

N/A

1.6DataRank · unranked

67 citations

Jungmin Lee, Bo Gao, Rowan Miller, Jung‐Yun Lee, Nicoletta Colombo +8 more

Prexasertib, a cell cycle checkpoint kinase 1 inhibitor, in BRCA mutant recurrent high-grade serous ovarian cancer (HGSOC): A proof-of-concept single arm phase II study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6038

N/A

0DataRank · unranked

7 citations

Daniel An, Ann McCoy, Elise C. Kohn, Christina M. Annunziata, Kathryn Trewhitt +4 more

Recent advancements of antiangiogenic combination therapies in ovarian cancer

Cancer Treatment Reviews(2021)10.1016/j.ctrv.2021.102224

N/A

0DataRank · unranked

80 citations

Susana Banerjee, Jungmin Lee, Daniel An

Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.07.031

N/A

0DataRank · unranked

31 citations

Christina M. Annunziata, John L. Hays, Liang Cao, Peter L. Choyke, Minshu Yu +8 more

The role of innate immune system in modulating CHK1 inhibitor (CHK1i) response in BRCA wild-type (BRCAwt), platinum-resistant high-grade serous ovarian cancer (PR-HGSOC): Exploratory analysis from a phase II study of CHK1i prexasertib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5557

N/A

0DataRank · unranked

1 citations

Jayakumar R. Nair, Tzu‐Ting Huang, Min-Jung Lee, Jane B. Trepel, Jungmin Lee +1 more

The KIF18A Inhibitor ATX020 Induces Mitotic Arrest and DNA Damage in Chromosomally Instable High-Grade Serous Ovarian Cancer Cells

Cells(2025)10.3390/cells14231863

N/A

0DataRank · unranked

3 citations

Tzu‐Ting Huang, Maureen M. Lynes, Sanjoy K. Khan, Serena J. Silver, Jungmin Lee +1 more

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

The Lancet Oncology(2022)10.1016/s1470-2045(22)00139-5

N/A

0DataRank · unranked

142 citations

Antonio González-Martı́n, Domenica Lorusso, Charlie Gourley, Mansoor Raza Mirza, Jean‐Emmanuel Kurtz +73 more